Condition: Long QT Syndrome Type 3 · Long QT Syndrome 2 · Sponsor: Thryv Therapeutics, Inc.
This is a cross-sectional observational study designed to assess the disease burden and quality of life in individuals with LQTS 2 and 3. Each participant will answer each patient-reported outcome questionnaire only once over a 6-month period. The study will enroll up to 200 participants.
This description comes directly from the study's public registry record.
Study Coordinator · 252-955-4157 · coordinator@myqtwave.com
Always discuss trial participation with your own doctor first.
| East Carolina University | Greenville, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07075445